News Quantified

FENC – fennec pharmaceuticals inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute [Yahoo! Finance]

Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute

Fennec Presents Real World Data Supporting Pedmark Use in Treating Adults with Head & Neck Cancers [Yahoo! Finance]

Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers

Adherex Technologies (NASDAQ:FENC) was upgraded by analysts at B.Riley Securit to a "strong-buy" rating.

3.8%

BEAT

-7.8%

MISS

-0.5%

BEAT

-11.4%

MISS

Form S-8 FENNEC PHARMACEUTICALS

Form 8-K FENNEC PHARMACEUTICALS For: Mar 04

Form 4 FENNEC PHARMACEUTICALS For: Feb 28 Filed by: Andrade Robert

Form 4 FENNEC PHARMACEUTICALS For: Feb 28 Filed by: Raykov Rosty

Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty

Top News Gainers

4/13 Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™ 11.9%

3/5 Form 8-K FENNEC PHARMACEUTICALS For: Mar 05 8.0%

2/11 Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency 7.8%

7/30 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%

12/23 Hedge Funds Aren’t Crazy About Contango Oil & Gas Company (MCF) Anymore [Yahoo! Finance News] 3.7%

2/14 Q4/2019 12/31/2019 EPS -0.180 ZacksConsensus N/A ActVsEst N/A - N/A 3.6%

5/16 Form DEF 14A FENNEC PHARMACEUTICALS For: Jun 18 1.9%

2/18 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. 1.7%

5/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 1.7%

4/30 Fennec Announces Pricing of Public Offering 1.6%

Top News Decliners

4/29 Fennec Announces Proposed Public Offering of Common Shares -13.6%

4/15 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -11.9%

6/19 Fennec Announces Results of Annual Meeting -8.0%

4/7 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.7%

1/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.9%

4/13 Form 8-K FENNEC PHARMACEUTICALS For: Apr 13 -3.9%

12/2 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -3.7%

5/9 Form 8-K FENNEC PHARMACEUTICALS For: May 09 -2.6%

6/26 Form S-8 FENNEC PHARMACEUTICALS -2.4%

11/12 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.230 ActVsEst 0.140 - Beat -2.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day